Afinitor News
Most Popular Afinitor Story
In cancer, it's AZ vs. Roche, Afinitor vs. everything
Two big cancer stories today, and it's not even time for ASCO yet. First, a battle for Europe's lung cancer patients is brewing, as an old AstraZeneca drug gets a new lease on life from personalized Read more...
Latest Headlines
- December 8, 2011
- September 26, 2011
- July 25, 2011
- July 8, 2011
- June 24, 2011
- April 19, 2011
- April 13, 2011
- April 11, 2011
- February 10, 2011
- July 2, 2010
- February 9, 2010
- June 8, 2009
- April 24, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
